Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released May 2, 2023, before the open
10-Q filed May 2, 2023, 32 days after period end · 0001558370-23-007675
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Revenue | $11.47M | $1.50M | $35.00K | — |
| Net Income | -$52.18M | -$52.76M | $43.75M | -$34.16M |
| EPS Diluted |
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
| -$0.92 |
| -$1.05 |
| $0.90 |
| -$0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.